These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31724242)

  • 1. Association Between Toll-Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Genetic Variants and Clinical Progression of Huntington's Disease.
    Vuono R; Kouli A; Legault EM; Chagnon L; Allinson KS; La Spada A; ; Biunno I; Barker RA; Drouin-Ouellet J
    Mov Disord; 2020 Mar; 35(3):401-408. PubMed ID: 31724242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
    Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
    JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation.
    Zhou J; Yu W; Zhang M; Tian X; Li Y; Lü Y
    Neurochem Res; 2019 May; 44(5):1138-1151. PubMed ID: 30756214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triggering receptor expressed on myeloid cells 2 activation downregulates toll-like receptor 4 expression and ameliorates cognitive impairment in the Aβ
    Qin Z; Gu M; Zhou J; Zhang W; Zhao N; Lü Y; Yu W
    Synapse; 2020 Oct; 74(10):e22161. PubMed ID: 32412103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease.
    Cheng-Hathaway PJ; Reed-Geaghan EG; Jay TR; Casali BT; Bemiller SM; Puntambekar SS; von Saucken VE; Williams RY; Karlo JC; Moutinho M; Xu G; Ransohoff RM; Lamb BT; Landreth GE
    Mol Neurodegener; 2018 Jun; 13(1):29. PubMed ID: 29859094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
    Moss DJH; Pardiñas AF; Langbehn D; Lo K; Leavitt BR; Roos R; Durr A; Mead S; ; ; Holmans P; Jones L; Tabrizi SJ
    Lancet Neurol; 2017 Sep; 16(9):701-711. PubMed ID: 28642124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans.
    Xiang X; Piers TM; Wefers B; Zhu K; Mallach A; Brunner B; Kleinberger G; Song W; Colonna M; Herms J; Wurst W; Pocock JM; Haass C
    Mol Neurodegener; 2018 Sep; 13(1):49. PubMed ID: 30185230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant
    Cheng Q; Danao J; Talreja S; Wen P; Yin J; Sun N; Li CM; Chui D; Tran D; Koirala S; Chen H; Foltz IN; Wang S; Sambashivan S
    J Biol Chem; 2018 Aug; 293(32):12620-12633. PubMed ID: 29599291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) R47H Variant Causes Distinct Age- and Sex-Dependent Musculoskeletal Alterations in Mice.
    Essex AL; Huot JR; Deosthale P; Wagner A; Figueras J; Davis A; Damrath J; Pin F; Wallace J; Bonetto A; Plotkin LI
    J Bone Miner Res; 2022 Jul; 37(7):1366-1381. PubMed ID: 35575023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
    Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
    Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coding variants in TREM2 increase risk for Alzheimer's disease.
    Jin SC; Benitez BA; Karch CM; Cooper B; Skorupa T; Carrell D; Norton JB; Hsu S; Harari O; Cai Y; Bertelsen S; Goate AM; Cruchaga C
    Hum Mol Genet; 2014 Nov; 23(21):5838-46. PubMed ID: 24899047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREM2 variants in Alzheimer's disease.
    Guerreiro R; Wojtas A; Bras J; Carrasquillo M; Rogaeva E; Majounie E; Cruchaga C; Sassi C; Kauwe JS; Younkin S; Hazrati L; Collinge J; Pocock J; Lashley T; Williams J; Lambert JC; Amouyel P; Goate A; Rademakers R; Morgan K; Powell J; St George-Hyslop P; Singleton A; Hardy J;
    N Engl J Med; 2013 Jan; 368(2):117-27. PubMed ID: 23150934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2.
    Sudom A; Talreja S; Danao J; Bragg E; Kegel R; Min X; Richardson J; Zhang Z; Sharkov N; Marcora E; Thibault S; Bradley J; Wood S; Lim AC; Chen H; Wang S; Foltz IN; Sambashivan S; Wang Z
    J Biol Chem; 2018 Aug; 293(32):12634-12646. PubMed ID: 29794134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid neurogranin and TREM2 in Huntington's disease.
    Byrne LM; Rodrigues FB; Johnson EB; De Vita E; Blennow K; Scahill R; Zetterberg H; Heslegrave A; Wild EJ
    Sci Rep; 2018 Mar; 8(1):4260. PubMed ID: 29523800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREM2 rare variant p.R47H is not associated with Parkinson's disease.
    Mengel D; Thelen M; Balzer-Geldsetzer M; Söling C; Bach JP; Schaeffer E; Herold C; Becker T; Liepelt I; Becker J; Riedel-Heller S; Scherer M; Jessen F; Maier W; Dodel R; Ramirez A
    Parkinsonism Relat Disord; 2016 Feb; 23():109-11. PubMed ID: 26651418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iPSC-derived microglia carrying the TREM2 R47H/+ mutation are proinflammatory and promote synapse loss.
    Penney J; Ralvenius WT; Loon A; Cerit O; Dileep V; Milo B; Pao PC; Woolf H; Tsai LH
    Glia; 2024 Feb; 72(2):452-469. PubMed ID: 37969043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p.R47H Variant of TREM2 Gene is Associated With Late-onset Alzheimer Disease in Colombian Population.
    Arboleda-Bustos CE; Ortega-Rojas J; Mahecha MF; Arboleda G; Vásquez R; Pardo R; Arboleda H
    Alzheimer Dis Assoc Disord; 2018; 32(4):305-308. PubMed ID: 30222607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential splicing of neuronal genes in a Trem2*R47H mouse model mimics alterations associated with Alzheimer's disease.
    Pandey RS; Kotredes KP; Sasner M; Howell GR; Carter GW
    BMC Genomics; 2023 Apr; 24(1):172. PubMed ID: 37016304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of TREM2 expression exacerbates neuroinflammatory responses through TLR4-mediated MAPK signaling pathway in a transgenic mouse model of Alzheimer's disease.
    Ruganzu JB; Peng X; He Y; Wu X; Zheng Q; Ding B; Lin C; Guo H; Yang Z; Zhang X; Yang W
    Mol Immunol; 2022 Feb; 142():22-36. PubMed ID: 34959070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IPSC-Derived Neuronal Cultures Carrying the Alzheimer's Disease Associated
    Martins S; Müller-Schiffmann A; Erichsen L; Bohndorf M; Wruck W; Sleegers K; Van Broeckhoven C; Korth C; Adjaye J
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.